Edison Pharmaceuticals Lands $50,000,135 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e938c2a-6d18-4892-8965-a6db95889051 - Date
3/28/2014 - Company Name
Edison Pharmaceuticals - Mailing Address
350 N. Bernardo Ave Mountain View, CA 94043 USA - Company Description
Edison’s business is the development of drugs to treat diseases that impair energy metabolism. Energy impairment diseases can be classified on the basis of whether they are inherited or acquired, and furthermore on the location of the defect. Edison is initially focusing on inherited diseases of the mitochondria- nature’s biological energy substation. - Website
http://www.edisonpharma.com - Transaction Type
Venture Equity - Transaction Amount
$50,000,135 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
